Cell transport machinery and its link to Parkinson’s and nerve cell health
Increasing the Complexity of Microtubule-based transport: Cargo adaptors and Hitchhiking on Vesicles.
This research looks at how tiny transport systems inside nerve cells, including a Parkinson’s-linked protein, change the movement of cargo and affect nerve cell health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11175297 on NIH RePORTER |
What this research studies
From my perspective, scientists are examining how molecular motors and adaptor proteins move organelles and vesicles along the cell's internal 'tracks' in nerve cells. They focus on two transport modes—direct adaptor binding and 'hitchhiking' on Rab-marked vesicles—and on how a phosphorylation site targeted by the Parkinson’s-linked kinase LRRK2 alters these interactions. The team uses cell models and biochemical experiments to observe how changes affect cargo loading, movement, and overall cell function. The findings aim to clarify how transport problems contribute to neurodevelopmental and neurodegenerative diseases.
Who could benefit from this research
Good fit: People with Parkinson’s disease or similar neurodegenerative conditions would be most likely to benefit from future clinical applications of this research.
Not a fit: People without neurological disorders and those seeking immediate clinical treatments would be unlikely to see direct benefits from this basic laboratory-focused project.
Why it matters
Potential benefit: If successful, this work could point to new targets or biomarkers that guide future treatments for Parkinson’s and related nerve disorders.
How similar studies have performed: Previous laboratory studies have linked motor protein dysfunction and LRRK2 activity to Parkinson’s, but turning those findings into effective therapies remains at an early stage.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Salogiannis, John — University of Vermont & St Agric College
- Study coordinator: Salogiannis, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.